CYP2U1 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP2U1 monoclonal antibodies for research applications. CYP2U1 Antibodies are validated for multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP2U1 is a member of the cytochrome P450 superfamily, which plays a crucial role in the metabolism of various endogenous and exogenous compounds. The enzyme actively participates in the oxidative metabolism of fatty acids and contributes to the regulation of lipid homeostasis. Understanding CYP2U1 function is essential for elucidating potential implications in drug metabolism and various disease states. Researchers worldwide utilize CYP2U1 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. Current studies focus on exploring CYP2U1's role in metabolic disorders and therapeutic development. Ongoing research continues to reveal new insights about CYP2U1's biological significance and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of CYP2U1 and its impact on human health.